Rankings
▼
Calendar
DNA Q4 2025 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
-23.8% YoY
Gross Profit
$42M
124.4% margin
Operating Income
-$71M
-211.9% margin
Net Income
-$81M
-241.8% margin
EPS (Diluted)
$-1.43
QoQ Revenue Growth
-14.0%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$63M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$611M
Stockholders' Equity
$509M
Cash & Equivalents
$167M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$33M
$44M
-23.8%
Gross Profit
$42M
$34M
+21.4%
Operating Income
-$71M
-$104M
+31.7%
Net Income
-$81M
-$108M
+24.9%
Revenue Segments
Service
$17M
100%
← FY 2025
All Quarters